Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone : Analysis of the Austrian head and neck cancer registry of the AGMT.

Magnes, T; Wagner, SM; Melchardt, T; Weiss, L; Rinnerthaler, G; Huemer, F; Kopp, M; Gampenrieder, SP; Mayrbäurl, B; Füreder, T; Lenger, D; Andel, J; Egle, A; Greil, R. Wien Klin Wochenschr. 2021 Sep 15. doi: 10.1007/s00508-021-01939-3. Online ahead of print.

Selective Activation of CNS and Reference PPARGC1A Promoters Is As-sociated with Distinct Gene Programs Relevant for Neurodegenerative Diseases.

Kwik, M; Hainzl, S; Oppelt, J; Tichy, B; Koller, U; Bernardinelli, E; Steiner, M; Zara, G; Nofziger, C; Weis, S; Paulmichl, M; Dossena, S; Patsch, W; Soyal, SM. Int J Mol Sci. 2021 Mar 24;22(7):3296. doi: 10.3390/ijms22073296.

Prognostic and Predictive Factors in Advanced Head and Neck Squamous Cell Carcinoma.

Magnes, T; Wagner, S; Kiem, D; Weiss, L; Rinnerthaler, G; Greil, R; Melchardt, T. Int J Mol Sci. 2021 May 7;22(9):4981. doi: 10.3390/ijms22094981.

SAMHD1 restrains aberrant nucleotide insertions at repair junctions generated by DNA end joining.

Akimova, E; Gassner, FJ; Schubert, M; Rebhandl, S; Arzt, C; Rauscher, S; Tober, V; Zaborsky, N; Greil, R; Geisberger, R. Nucleic Acids Res. 2021 Mar 18;49(5):2598-2608. doi: 10.1093/nar/gkab051.

Conventional versus reverse sequence of neoadjuvant epirubi-cin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34.

Bartsch, R; Singer, CF; Pfeiler, G; Hubalek, M; Stoeger, H; Pichler, A; Petru, E; Bjelic-Radisic, V; Greil, R; Rudas, M; Muy-Kheng, TM; Wette, V; Petzer, AL; Sevelda, P; Egle, D; Dubsky, PC; Filipits, M; Fitzal, F; Exner, R; Jakesz, R; Balic, M; Tinchon, C; Bago-Horvath, Z; Frantal, S; Gnant, M. Br J Cancer. 2021 May;124(11):1795-1802. doi: 10.1038/s41416-021-01284-2. Epub 2021 Mar 24.

Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34.

Bartsch, R; Singer, CF; Pfeiler, G; Hubalek, M; Stoeger, H; Pichler, A; Petru, E; Bjelic-Radisic, V; Greil, R; Rudas, M; Muy-Kheng, TM; Wette, V; Petzer, AL; Sevelda, P; Egle, D; Dubsky, PC; Filipits, M; Fitzal, F; Exner, R; Jakesz, R; Balic, M; Tinchon, C; Bago-Horvath, Z; Frantal, S; Gnant, M. Br J Cancer. 2021 May;124(11):1795-1802. doi: 10.1038/s41416-021-01284-2. Epub 2021 Mar 24.

Austrian recommendations for the management of essential thrombocythemia.

Buxhofer-Ausch, V; Heibl, S; Sliwa, T; Beham-Schmid, C; Wolf, D; Geissler, K; Krauth, MT; Krippl, P; Petzer, A; Wolfler, A; Melchardt, T; Gisslinger, H. Wien Klin Wochenschr. 2021 Jan;133(1-2):52-61. doi: 10.1007/s00508-020-01761-3. Epub 2020 Nov 19.

Cytotoxic constituents and a new hydroxycinnamic acid derivative from Leontodon saxatilis (Asteraceae, Cichorieae).

Cicek, SS; Willer, J; Preziuso, F; Sonnichsen, F; Greil, R; Girreser, U; Zidorn, C; Johrer, K. RSC ADV. 2021; 11(18): 10489-10496. DOI: 10.1039/d0ra10973h

A clinical validation study of MammaPrint in hormone receptor-positive breast cancer from the Austrian Breast and Colorectal Cancer Study Group 8 (ABCSG-8) biomarker cohort.

Dubsky, P; Vant Veer, L; Gnant, M; Rudas, M; Bago-Horvath, Z; Greil, R; Lujinovic, E; Buresch, J; Rinnerthaler, G; Hulla, W; Moinfar, F; Egle, D; Herz, W; Dreezen, C; Frantal, S; Filipits, M. ESMO Open. 2021 Feb;6(1):100006. doi: 10.1016/j.esmoop.2020.100006. Epub 2020 Dec 31.

Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy.

Hatzl, S; Posch, F; Rezai, A; Gornicec, M; Beham-Schmid, C; Magnes, T; Wangner, S; Deutsch, A; Greinix, H; Uhl, B; Prochazka, KT; Egle, A; Greil, R; Melchardt, T; Linkesch, W; Schulz, E; Neumeister, P. Support Care Cancer. 2021 Feb 24. doi: 10.1007/s00520-021-06059-2. Online ahead of print.